Sven-Goran Eriksson's England memorabilia up for auction after dying '£8.6million in debt'
The late former England manager was indebted by £8.64m (118 million Swedish Krona), with assets totalling only £4.8m, ...
Sven-Goran Eriksson's memorabilia from his managerial career goes up for auction - including England momentos - after he died '£3.7m in debt'
Ninety-eight items are up for sale including blazers from his England days, medals from his achievements in Italian football, ...
Sven-Goran Eriksson’s life memorabilia put up for auction in attempt to clear debts
An extraordinary selection of memorabilia that belonged to Sven-Goran Eriksson, the former England manager, has gone up for ...
Sven-Goran Eriksson's memorabilia from his life in management goes up for sale - including England momentos - after he died '£3.7m in debt'
Ninety-eight items are up for sale including blazers from his England days, medals from his achievements in Italian football, and his second managerial contract at Gotehenberg from 1979 ...
The Daily Telegraph6d
Sven-Goran Eriksson’s life memorabilia put up for auction in attempt to clear debts
An extraordinary selection of memorabilia that belonged to Sven-Goran Eriksson, the former England ... and Customs when he died of pancreatic cancer aged 76. Citing information released by the ...
Need more of what Kettle’s started
A weekly newsletter poring over the past, present, and future of the beautiful game ...
ELLE5d
Cancer Daily Horoscope
Charm and luck are on your side this Saturday when magnetic Venus tangos with bold Mars, who’s rolling retrograde in Cancer. You have the ability now to exude enthusiasm that will quickly and ...
telecomasia.net6d
Sven-Göran Eriksson's Personal Belongings Up for Auction
According to Aftonbladet, personal items belonging to former England national football team manager Sven-Göran Eriksson are now being auctioned. The Swedish coach passed away on August 26, 2024, at ...
Science Daily3d
Cancer News
Jan. 25, 2025 — Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the targeted therapies encorafenib and cetuximab plus a ...